AOBLX
Price
$11.00
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Net Assets
390.21M
RLBCX
Price
$34.67
Change
+$0.03 (+0.09%)
Updated
May 22 closing price
Net Assets
237.69B
Interact to see
Advertisement

AOBLX vs RLBCX

Header iconAOBLX vs RLBCX Comparison
Open Charts AOBLX vs RLBCXBanner chart's image
Victory Pioneer Balanced A
Price$11.00
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets390.21M
American Funds American Balanced R3
Price$34.67
Change+$0.03 (+0.09%)
VolumeN/A
Net Assets237.69B
AOBLX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AOBLX vs. RLBCX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AOBLX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 238B vs. AOBLX (390M). AOBLX pays higher dividends than RLBCX: AOBLX (1.95) vs RLBCX (1.70). AOBLX was incepted earlier than RLBCX: AOBLX (33 years) vs RLBCX (23 years). AOBLX (0.94) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. AOBLX (33.00). RLBCX has a lower initial minimum investment than AOBLX: RLBCX (250) vs AOBLX (1000). RLBCX annual gain was more profitable for investors over the last year : 4.44 vs. AOBLX (2.85). RLBCX return over 5 years is better than : 36.27 vs. AOBLX (31.87).
AOBLXRLBCXAOBLX / RLBCX
Total Expense Ratio0.940.89106%
Annual Report Gross Expense Ratio0.940.89106%
Fund Existence33 years23 years-
Gain YTD0.3671.88120%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets390M238B0%
Annual Yield % from dividends1.951.70115%
Returns for 1 year2.854.4464%
Returns for 3 years22.0221.68102%
Returns for 5 years31.8736.2788%
Returns for 10 years37.0249.7274%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ULBI5.530.14
+2.60%
Ultralife Corp
RUN10.66N/A
N/A
Sunrun
AMCR9.05N/A
N/A
Amcor plc
UWMC3.97N/A
N/A
UWM Holdings Corp
LYRA0.09N/A
-1.70%
Lyra Therapeutics